{
  "company": {
    "name": "MPC Therapeutics",
    "website": "https://mpc-therapeutics.com/",
    "record": "https://startuphistory.org/c/mpc-therapeutics.com"
  },
  "status": null,
  "history_since": "2022-04-22T13:24:15.000Z",
  "baseline": {
    "snapshot_id": "2f9684417337dbe31e248ffc2bd57fd8844bec506f6262db49f7c18ab028fffa",
    "observed_at": "2022-04-22T13:24:15.000Z",
    "headline": null,
    "description": "We develop a new generation of drugs targeting mitochondria",
    "evidence": "https://web.archive.org/web/20220422132415/https://www.mpc-therapeutics.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:45:24.814Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-06T17:45:24.814Z",
      "variants": [
        {
          "headline": "MPC Therapeutics - enhancing cell therapies",
          "subhead": "MPC Therapeutics is a Swiss biotech developing a universal T cell supplement designed to enhance the fitness and persistence of cell therapies against cancer.",
          "observed_at": "2025-07-13T20:27:44.000Z",
          "evidence": "https://web.archive.org/web/20250713202744/https://www.mpc-therapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Enhancing cell therapies | MPC Therapeutics",
          "subhead": "MPC Therapeutics is a Swiss biotech developing a universal T cell supplement designed to enhance the fitness and persistence of cell therapies against cancer.",
          "observed_at": "2026-01-17T06:53:26.000Z",
          "evidence": "https://web.archive.org/web/20260117065326/https://www.mpc-therapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Enhancing cell therapies | MPC Therapeutics",
          "subhead": "MPC Therapeutics is a Swiss biotech developing a universal T cell supplement designed to enhance the fitness and persistence of cell therapies against cancer.",
          "observed_at": "2026-11-06T17:45:24.814Z",
          "evidence": "https://www.mpc-therapeutics.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Enhancing cell therapies | MPC Therapeutics",
      "subhead": "MPC Therapeutics is a Swiss biotech developing a universal T cell supplement designed to enhance the fitness and persistence of cell therapies against cancer.",
      "from": "2025-07-13T20:27:44.000Z",
      "to": "2026-11-06T17:45:24.814Z",
      "captures": 3,
      "evidence": "https://www.mpc-therapeutics.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2025-07-13T20:27:44.000Z",
          "to": "2026-11-06T17:45:24.814Z"
        }
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “MPC Therapeutics” company record, https://startuphistory.org/c/mpc-therapeutics.com"
}